Fibrous Dysplasia in the Alveolar Crest of Edentulous Site and the Curettage for Future Implant Placement: a Case Report

Overview

Journal BMC Oral Health

Publisher Biomed Central

Specialty Dentistry

Date 2025 Jan 3

PMID 39748296

Authors

Hao Chen

Yuting Wen

Xueqi Guo

Shiyong Zhao

Affiliations

Soon will be listed here.

Abstract

Background: Fibrous dysplasia (FD) is a self-limiting benign disease with slow progression in which the normal bone is replaced by dysplastic fibrous tissue. The craniofacial skeleton is one of the most commonly affected areas, and it can create unique challenges in dental implant therapy. This case aims to report an unusual presentation of FD localized in the alveolar crest bone of the edentulous site, causing special obstacles to implant placement, and provide a diagnostic and treatment process that may be referenced.

Case Presentation: A 32-year-old female patient presented with an abnormal expansion of the alveolar crest on the edentulous site of the mandibular first molar, which caused insufficient inter-arch space and pseudo-pocket in the adjacent teeth, previous medical history of residual root that existed for many years before tooth extraction was identified retrospectively. FD was diagnosed by the clinical, radiographic, and pathological examination, and the curettage was performed to remove abnormal bone tissue and obtain adequate restorative space for further implant therapy. This intervention was followed by histologically confirmed healing and successfully integrated implant placement.

Conclusion: We described an unreported pathogenic site of FD that occurred at the alveolar ridge of the edentulous site, which ended up with satisfactory oral implant rehabilitation through 5-year sequential diagnosis and treatment.

References

Ikuta K, Sakai T, Koike H, Ito K, Imagama S, Nishida Y . Successful treatment with denosumab for pelvic fibrous dysplasia: A case report and review of the literature. Medicine (Baltimore). 2021; 100(49):e28138. PMC: 8663861. DOI: 10.1097/MD.0000000000028138. View

Kabali T, Moshy J, Owibingire S, Sohal K, Simon E . Craniofacial fibrous dysplasia associated with McCune-Albright syndrome: challenges in diagnosis and treatment: case reports. BMC Oral Health. 2019; 19(1):180. PMC: 6686505. DOI: 10.1186/s12903-019-0872-8. View

Bajwa M, Ethunandan M, Flood T . Oral rehabilitation with endosseous implants in a patient with fibrous dysplasia (McCune-Albright syndrome): a case report. J Oral Maxillofac Surg. 2008; 66(12):2605-8. DOI: 10.1016/j.joms.2007.06.669. View

Javaid M, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A . Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet J Rare Dis. 2019; 14(1):139. PMC: 6567644. DOI: 10.1186/s13023-019-1102-9. View

Pacino G, Cocuzza S, Tonoli G, Rizzo P, Tirelli G, Tofanelli M . Jawbone fibrous dysplasia: retrospective evaluation in a cases series surgically treated and short review of the literature. Acta Biomed. 2021; 92(1):e2021018. PMC: 7975924. DOI: 10.23750/abm.v92i1.9904. View

Burke A, Collins M, Boyce A . Fibrous dysplasia of bone: craniofacial and dental implications. Oral Dis. 2016; 23(6):697-708. PMC: 5292317. DOI: 10.1111/odi.12563. View

Schlabe J, Echlin K, Atherton D . A comparison of piezo surgery osteotomies with conventional internal osteotomies as performed by trainee surgeons: a cadaveric study. Ann R Coll Surg Engl. 2021; 103(4):272-277. PMC: 10335209. DOI: 10.1308/rcsann.2020.7120. View

Chapurlat R, Hugueny P, Delmas P, Meunier P . Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment. Bone. 2004; 35(1):235-42. DOI: 10.1016/j.bone.2004.03.004. View

Mete O, Wenig B . Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms. Head Neck Pathol. 2022; 16(1):123-142. PMC: 9018952. DOI: 10.1007/s12105-022-01435-8. View

10.

Ishida K, Sakamoto Y, Kosugi K, Miwa T, Toda M . The Long-Term Natural History of Fibrous Dysplasia. J Craniofac Surg. 2024; . DOI: 10.1097/SCS.0000000000010245. View

11.

Florez H, Peris P, Guanabens N . Fibrous dysplasia. Clinical review and therapeutic management. Med Clin (Barc). 2016; 147(12):547-553. DOI: 10.1016/j.medcli.2016.07.030. View

12.

Xu Y, Li Y, Dong H, Zhao S, Yang P, Dai C . Craniofacial Fibrous Dysplasia in Fronto-Orbital Region: A Single-Center Retrospective Study of 38 Cases. World Neurosurg. 2023; 181:e1130-e1137. DOI: 10.1016/j.wneu.2023.11.054. View

13.

Lee J, FitzGibbon E, Chen Y, Kim H, Lustig L, Akintoye S . Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet J Rare Dis. 2012; 7 Suppl 1:S2. PMC: 3359960. DOI: 10.1186/1750-1172-7-S1-S2. View

14.

Simm P, Biggin A, Zacharin M, Rodda C, Tham E, Siafarikas A . Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health. 2018; 54(3):223-233. DOI: 10.1111/jpc.13768. View

15.

Abd Elalim M, Ettish A, Elfeky W, Abdelaal M . Case Report Of Rib Polyostotic Fibrous Dysplasia. J Pak Med Assoc. 2023; 73(Suppl 4)(4):S334-S336. DOI: 10.47391/JPMA.EGY-S4-63. View

16.

Babu RS A, Ogle O . Tissue response: biomaterials, dental implants, and compromised osseous tissue. Dent Clin North Am. 2015; 59(2):305-15. DOI: 10.1016/j.cden.2014.10.010. View

17.

Sontakke S, Karjodkar F, Umarji H . Computed tomographic features of fibrous dysplasia of maxillofacial region. Imaging Sci Dent. 2011; 41(1):23-8. PMC: 3174456. DOI: 10.5624/isd.2011.41.1.23. View

18.

Meier M, Vago E, Abrahamsen B, Dekkers O, Horvath-Puho E, Rejnmark L . Incidence and Prevalence of Fibrous Dysplasia/McCune-Albright Syndrome: A Nationwide Registry-Based Study in Denmark. J Clin Endocrinol Metab. 2024; 109(6):1423-1432. PMC: 11099484. DOI: 10.1210/clinem/dgad744. View

19.

Sivolella S, Brunello G, Fistarol F, Stellini E, Bacci C . The bone lid technique in oral surgery: a case series study. Int J Oral Maxillofac Surg. 2017; 46(11):1490-1496. DOI: 10.1016/j.ijom.2017.06.027. View

20.

Motomura T, Kasayama S, Takagi M, Kurebayashi S, Matsui H, Hirose T . Increased interleukin-6 production in mouse osteoblastic MC3T3-E1 cells expressing activating mutant of the stimulatory G protein. J Bone Miner Res. 1998; 13(7):1084-91. DOI: 10.1359/jbmr.1998.13.7.1084. View